Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.
Accidental discovery. Life changing consequence. Happens all the time, doesn’t it? Penicillin wouldn’t have been discovered if Alexander Fleming hadn’t observed unusual growth in his lab equipment. For others in the life sciences industry—particularly in compliance—discoveries don’t always have happy endings. Data discoveries are best made quickly and internally. Yet, that doesn’t seem to happen […]
At qordata, we’re driven by an aggressive ‘myth-busting’ mission when it comes to the Pharma Compliance/Transparency space. And one way we measure our effectiveness is by seeking participant responses during the webinars we conduct. In our most recent webinar, in which I hosted Wendy Derosa and Bryan Timer from Merck USA, the poll results suggested […]
How does a member of the Big Pharma Club manage to have a sophisticated Compliance/Transparency Platform? Is the picture complicated while overseeing the information needs of a global firm with annual sales exceeding $10.1 billion (Q4 2016)? Our friends from Merck USA responded to both questions in a qordata webinar they presented in March 2017. […]
Putting outlook toward pre-CMS submission analytics to the test, qordata conducted a poll during its webinar earlier this month. The question was: “How important are analytics for reviewing spend prior to submission?” The results were unsurprising: 63% of participants believed using analytics prior to CMS submission was “Very Important,” with another 31% saying it was […]
The landscape for Pharmaceutical Drug and Device Manufacturers in North America is changing, especially after the ratification of the Sunshine Payments Act. There’s more publicly available data for everyone—over 25 million records and counting—and much more public accountability accompanying it. Instead of waiting for competitors, the media, Public Prosecutors, or Civil Interest Groups to arrive at […]
There comes a point in life when one comes under the umbrella of rules and regulations. At times, these regulations don’t seem to add much benefit and, in a way, restrict activity unless an individual or an organization is ready to harness this change into something beneficial. The pharmaceutical industry is on the verge of […]
Your usage of this site constitutes acceptance of our Terms of Use & Data Policy. The material on this say may not be reproduced, distributed, transmitted, cached, or otherwise used without qordata’s consent. qordata is an Equal Opportunity Employer. All qualified individuals are accepted as employees and will receive consideration for employment without regard to race, gender, color, age, religion, sex, national origin, protected veteran status, or any other characteristic protected under federal, state, or local law.
© qordata 2024. All rights reserved | Sitemap | Privacy Policy | Terms of Use